BRTX

BioRestorative Therapies Inc. (BRTX), based in Melville, New York, is at the forefront of regenerative medicine, specializing in the development of innovative therapies leveraging adult stem cell technology. The company's mission is to meet significant unmet medical needs by delivering safe and effective treatments across key therapeutic areas such as orthopedics and neurology. With a commitment to advancing cellular and tissue-based methodologies, BRTX aims to play a vital role in the transformation of healthcare solutions, positioning itself as a key player in the evolving regenerative medicine landscape.